申请人:AstraZeneca, Intellectual Property
公开号:US20130150366A1
公开(公告)日:2013-06-13
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use in the treatment of bacterial infections are also described.
本文描述了化学式(I)的化合物及其药学上可接受的盐。还描述了制备它们的过程、含有它们的制药组合物,以及它们在治疗细菌感染方面的用途。